Frontiers
US$ 24.57
does glp 1 cause personality changes An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders Doctors and patients across social
Description
Widespread access to GLP-1 therapies could generate significant benefits to society and produce huge savings for Medicare, Schaeffer research shows
Foundayo and oral Wegovy have arrived
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed financial ties to obesity drugmakers, a paper finds.
- Jackson's Transformation
